PT. Penta Valent Tbk (IDX:PEVE)

Market Cap	900.47B
Revenue (ttm)	3.27T
Net Income (ttm)	58.52B
Shares Out	1.77B
EPS (ttm)	33.58
PE Ratio	15.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	355,700
Average Volume	2,344,395
Open	520.00
Previous Close	520.00
Day's Range	498.00 - 535.00
52-Week Range	228.00 - 740.00
Beta	0.31
RSI	55.75
Earnings Date	Oct 30, 2025

About PT. Penta Valent Tbk

PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. It operates through Pharmaceutical Products and Consumer Goods segments. The company offers medicinal products; over the counter drug products; medical supporting equipment, such as blood pressure meters, body thermometers, and others; reaction materials, such as blood sugar tests, pregnancy tests, or rapid tests for Covid-19, drug tests, etc.; and food supplements comprising minerals and nutrients. It also provides products for beau...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1968
• Employees: 971
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PEVE

Financial Performance

In 2024, PT. Penta Valent Tbk's revenue was 3.01 trillion, an increase of 21.25% compared to the previous year's 2.48 trillion. Earnings were 48.01 billion, an increase of 32.73%.